CI Jun 2025 450.000 call
| Previous close | 3.3000 |
| Open | 3.0000 |
| Bid | 6.5000 |
| Ask | 8.1000 |
| Strike | 450.00 |
| Expiry date | 2025-06-20 |
| Day's range | 3.0000 - 3.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 119 |
ZacksWhy Cigna (CI) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PR NewswireThe Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
The Cigna Group (NYSE: CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to allocate a collective $25,000 donation among three nonprofits: National Council for Mental Wellbeing, National Coalition for Homeless Veteran
PR NewswireEvernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025. The interchangeable biosimilar will be produced for Evernorth's affiliate private label distributor, Quallent Pharmaceuticals. It will be available at $0 out of pocket for most patients through Quallent's copay assistance program. This program is expected to save individual patients around $4,000 on averag
